tiprankstipranks
Extendicare (TSE:EXE)
TSX:EXE
Canadian Market

Extendicare (EXE) Technical Analysis

Compare
184 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
13Bullish
0Neutral
0Bearish
Technical Analysis Consensus
Strong Buy
1Bullish
0Neutral
0Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Extendicare’s (EXE) Moving Averages Convergence Divergence (MACD) indicator is 0.32, suggesting Extendicare is a Buy.
Extendicare’s (EXE) 20-Day exponential moving average is 12.84, while Extendicare’s (EXE) share price is C$13, making it a Buy.
Extendicare’s (EXE) 50-Day exponential moving average is 12.08, while Extendicare’s (EXE) share price is C$13, making it a Buy.

Extendicare (EXE) Pivot Points

Apr 03, 2025, 10:17 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
12.57
12.67
12.78
12.88
12.99
13.09
13.20
Fibonacci
12.67
12.75
12.80
12.88
12.96
13.01
13.09
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Extendicare (EXE) Moving Averages

Apr 03, 2025, 10:17 AM
Period
Simple
Exponential
MA5
13.04Buy
13.09Buy
MA10
13.04Buy
13.03Buy
MA20
13.00Buy
12.84Buy
MA50
11.85Buy
12.08Buy
MA100
10.99Buy
11.17Buy
MA200
9.59Buy
9.82Buy
Extendicare’s (EXE) 10-Day exponential moving average is 13.03, while Extendicare’s (EXE) share price is C$13, making it a Buy.
Extendicare’s (EXE) 100-Day exponential moving average is 11.17, while Extendicare’s (EXE) share price is C$13, making it a Buy.
Extendicare’s (EXE) stock price is C$13 and Extendicare’s (EXE) 50-day simple moving average is 11.85, creating a Buy signal.
Extendicare’s (EXE) stock price is C$13 and Extendicare’s (EXE) 100-day simple moving average is 10.99, creating a Buy signal.
Extendicare’s (EXE) stock price is C$13 and Extendicare’s (EXE) 200-day simple moving average is 9.59, creating a Buy signal.

Extendicare (EXE) Technical Indicators

Apr 03, 2025, 10:17 AM
Name
Value
Implied Action
RSI (14)
65.84
Neutral
STOCH (9,6)
36.47
Neutral
STOCHRSI (14)
37.47
Neutral
MACD (12,26)
0.32
Buy
ADX (14)
33.94
Neutral
Williams %R
-55.56
Buy
CCI (14)
-44.73
Neutral
ATR (14)
0.30
-
Ultimate Oscillator
38.29
Neutral
ROC
4.64
Buy
Extendicare’s (EXE) Relative Strength Index (RSI) is 65.84, creating a Neutral signal.
Extendicare’s (EXE) Trend Strength Indicator (ADX) is 33.94, creating a Neutral signal.
Extendicare’s (EXE) Commodity Channel Index (CCI) is -44.73, creating a Neutral signal.
Extendicare’s (EXE) Price Rate of Change (ROC) is 4.64, creating a Buy signal.

FAQ

Is EXE a Buy, Hold, or Sell?
Based on EXE’s technical indicators, EXE is a Strong Buy.
    What is EXE’s RSI (14)?
    EXE’s RSI (14) is 65.84, which suggests EXE is a Neutral.
      What is EXE’s MACD?
      EXE’s MACD is 0.32, which suggests EXE is a Buy.
        What is EXE’s 5-day moving average?
        EXE’s 5-day moving average is 13.04, which suggests EXE is a Buy.
          What is EXE’s 20-day moving average?
          EXE 20-day moving average is 13.00, which suggests EXE is a Buy.
            What is EXE’s 50-day moving average?
            EXE’s 50-day moving average is 11.85, which suggests EXE is a Buy.
              What is EXE’s 200-day moving average?
              EXE’s 200-day moving average is 9.59, which suggests EXE is a Buy.
                What is EXE’s Williams % R (14)?
                EXE’s Williams % R (14) is -55.56, which suggests EXE is a Buy.
                  What is EXE’s CCI (14)?
                  EXE’s CCI (14) is -44.73, which suggests EXE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis